Published: 10 May 2023

Committees

Comments on agenda items for the 70th meeting of the Medicines Classification Committee to be held on 25 May 2023.

The Medicines Classification Committee and the Secretariat wish to thank everyone for their valuable input and feedback.

A total of 11 submissions (PDF 1.75MB, 58 pages) commenting on agenda items for the 70th meeting were received. Some of the submissions commented on more than one agenda item. Some parts of the comments have been withheld from publication for pursuant to the Official Information Act 1982.

Agenda Item 5.1a Low-dose cannabidiol

Six comments were received about this agenda item.

Agenda Item 5.6 Paracetamol (liquid formulations)

Two comments were received about this agenda item.

Agenda Item 5.7 Zinc

Three comments were received about this agenda item.

Agenda Item 5.9 National Immunisation Schedule

One comment was received about this agenda item.

Agenda Item 6.1a Ibuprofen 400 mg

Four comments were received about this agenda item.

Agenda Item 6.1b Trimethoprim

Five comments were received about this agenda item.

Agenda Item 6.1c Flurbiprofen

Three comments were received about this agenda item.

Agenda Item 6.1d Glecaprevir and Pibrentasvir (Maviret)

Three comments were received about this agenda item.

Agenda Item 6.1e Naproxen

Four comments were received about this agenda item.

Agenda Item 6.1f Bilastine

One comment was received about this agenda item.